FCFS
ARKG icon

First Command Financial Services’s ARK Genomic Revolution ETF ARKG Stock Holding History

First Command Financial Services’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-285
Closed -$10K – 426
2018
Q3 		$10K Hold
285
– – ﹤0.01% 329
2018
Q2 		$8K Hold
285
– – ﹤0.01% 354
2018
Q1 		$7K Buy
+285
New +$7.72K ﹤0.01% 374

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
Arlington Capital Management Arlington Heights, Illinois $177M AUM 44.15% 1-Year Est. Return
CFA
Carroll Financial Associates Charlotte, North Carolina $1.88B AUM 20.52% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Financial Engines Advisors
Financial Engines Advisors Santa Clara, California $49.2B AUM 14.31% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
MIAN
Mariner Independent Advisor Network Overland Park, Kansas $2.33B AUM 14.85% 1-Year Est. Return
SCA
Snowden Capital Advisors New York $3.76B AUM 23.4% 1-Year Est. Return

First Command Financial Services's ARKG Position: Q4 2018 in Review

First Command Financial Services sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2018, closing a stake of 285 shares — an estimated $10K sold.

First Command Financial Services first reported a position in ARKG in Q1 2018 and held it in 3 quarters. The position peaked at $10K in Q3 2018. 58 funds tracked by Wall St. Rank hold ARKG as of Q4 2018.

  • First Command Financial Services reported no remaining ARK Genomic Revolution ETF position as of Q4 2018 after selling out during the quarter.
  • First Command Financial Services sold 285 ARK Genomic Revolution ETF shares in Q4 2018, an estimated $10K.
  • First Command Financial Services first reported a position in ARK Genomic Revolution ETF in Q1 2018 and held it in 3 quarters.
  • First Command Financial Services's ARK Genomic Revolution ETF position peaked at $10K in Q3 2018.
  • 58 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2018.

Based on First Command Financial Services's 13F filing for Q4 2018, filed 24 Jan 2019.